期刊文献+

TYMS蛋白在原发性肝癌中的表达及预后评估价值分析

Expression of TYMS protein in primary liver cancer and its prognostic evaluation value analysis
下载PDF
导出
摘要 目的探讨胸苷酸合成酶(TYMS)蛋白在原发性肝细胞癌(HCC)中的表达水平及其对临床预后的评估价值。方法采用免疫组织化学染色法检测100例经病理学诊断为HCC患者癌组织及癌旁组织TYMS蛋白的表达情况,并进行量化评分,分析TYMS蛋白在不同临床病理特征患者中的表达情况,以及TYMS蛋白表达水平与HCC患者生存率的关系。结果TYMS蛋白表达水平在不同性别、年龄、肿瘤最大径、甲胎蛋白水平、乙型肝炎病毒-DNA水平等患者间比较,差异无统计学意义(P>0.05),低分化者TYMS蛋白表达阳性率(83.87%)高于中-高分化者(62.32%),差异有统计学意义(P<0.05)。TYMS蛋白在HCC癌组织的表达水平高于癌旁组织,差异有统计学意义(P<0.01)。3年总生存期分析结果显示,TYMS蛋白低表达者生存率(61.3%)明显高于高表达者(22.6%),差异有统计学意义(P<0.05)。结论TYMS蛋白在HCC癌组织中表达明显异常且与肿瘤组织分化程度、患者预后密切相关。抑制TYMS蛋白表达对HCC患者的治疗和预后有重要意义。 Objective To investigate the expression level of thymidylate synthase(TYMS)protein in primary hepatocellular carcinoma(HCC)and its clinical prognostic evaluation value.Methods The immunohistochemistry staining was used to detect the expression of TYMS protein in liver cancer tissues and paracancerous tissues of 100 patients with pathologically diagnosed HCC and the quantitative scoring was performed;the expression situation of TYMS protein in tissues with different clinicopathological features patients and the relationship between TYMS protein expression level and survival rate of the patients with HCC were analyzed.Results There was no statistically significant difference in the expression level of TYMS protein among the patients with different genders,ages,tumor maximal diameter,AFP level,HBV-DNA level etc.(P>0.05),the positive rate of TYMS protein expression in the low differentiation patients was 83.87%,which was higher than 62.32%in the medium differentiation and high differentiation patients,and the differences were statistically significant(P<0.05).The expression level of TYMS protein in HCC cancer tissues was higher than that in paracancerous tissues,and the difference was statistically significant(P<0.01),The 3-year overall survival analysis showed that the survival rate of the patients with TYMS protein low expression was 61.3%,which was significantly higher than 22.6%of the patients with TYMS protein high expression,and the difference was statistically significant(P<0.05).Conclusion The TYMS protein expression is significantly abnormal in HCC cancer tissue and closely correlated to the differentiation degree of cancer and the prognosis of the patients.Inhibiting TYMS protein expression has an important significance for the treatment and prognosis of the patients with HCC.
作者 黄丽芳 粟连秀 吕自力 HUANG Lifang;SU Lianxiu;LYU Zili(Department of Pathology,First Affiliated Hospital of Guangxi Medical University,Nanning,Guangxi 530021,China;Department of Pathology,Eighth Affiliated Hospital of Guangxi Medical University,Guigang,Guangxi 537100,China)
出处 《检验医学与临床》 CAS 2023年第1期14-17,共4页 Laboratory Medicine and Clinic
基金 广西壮族自治区卫生健康委员会自筹经费科研课题(Z20210848)。
关键词 原发性肝细胞癌 胸苷酸合成酶 生存分析 primary hepatocellular carcinoma thymidylate synthase survival analysis
  • 相关文献

参考文献4

二级参考文献16

  • 1王伟,曹胜利,郭燕文,王先波.胸苷酸合酶抑制剂研究进展[J].中国新药杂志,2005,14(6):693-696. 被引量:5
  • 2Maria J. Lamas,Goretti Duran,Antonio Gomez,Emilia Balboa,Urbano Anido,Beatriz Bernardez,Pablo Rana-Diez,Rafael Lopez,Angel Carracedo,Francisco Barros.X-Ray Cross-Complementing Group 1 and Thymidylate Synthase Polymorphisms Might Predict Response to Chemoradiotherapy in Rectal Cancer Patients[J].International Journal of Radiation Oncology Biology Physics.2012(1)
  • 3Maria J Lamas,Goretti Duran,Emilia Balboa,Beatriz Bernardez,Manuel Touris,Yolanda Vidal,Elena Gallardo,Rafael Lopez,Angel Carracedo,Francisco Barros.Use of a comprehensive panel of biomarkers to predict response to a fluorouracil&ndash;oxaliplatin regimen in patients with metastatic colorectal cancer[J].Pharmacogenomics.2011(3)
  • 4Roshawn G. Watson,Filipe Muhale,Leigh B. Thorne,Jinsheng Yu,Bert H. O’Neil,Janelle M. Hoskins,Michael O. Meyers,Allison M. Deal,Joseph G. Ibrahim,Michael L. Hudson,Christine M. Walko,Howard L. McLeod,James T. Auman.Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy[J].European Journal of Cancer.2010(18)
  • 5Zhao-Hui Huang,Dong Hua,Li-Hua Li.The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population[J].Cancer Chemotherapy and Pharmacology.2009(5)
  • 6Takanori Matsui,Kenji Omura,Kazuyuki Kawakami,Satoshi Morita,Junichi Sakamoto.Genotype of thymidylate synthase likely to affect efficacy of adjuvant5-FU based chemotherapy in colon cancer[J].Oncology Reports.2006(5)
  • 7Ayako Yawata,Su-Ryang Kim,Atsuko Miyajima,Takashi Kubo,Seiichi Ishida,Yoshiro Saito,Yukiko Nakajima,Noriko Katori,Yoshiaki Matsumoto,Masamichi Fukuoka,Yasuo Ohno,Shogo Ozawa,Jun-ichi Sawada.Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents[J].Cancer Chemotherapy and Pharmacology.2005(5)
  • 8Maria Morganti,Monica Ciantelli,Beatrice Giglioni,Anna L. Putignano,Stefania Nobili,Laura Papi,Ida Landini,Cristina Napoli,Rosa Valanzano,Fabio Cianchi,Vieri Boddi,Francesco Tonelli,Camillo Cortesini,Teresita Mazzei,Maurizio Genuardi,Enrico Mini.Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers[J].European Journal of Cancer.2005(14)
  • 9Masaki Kakimoto,Hiroyuki Uetake,Takayuki Osanai,Yoshinori Shirota,Yoko Takagi,Emiko Takeshita,Yoichi Toriya,Kathleen Danenberg,Peter V. Danenberg,Kenichi Sugihara.Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test[J].Cancer Letters.2004(1)
  • 10Sharon Marsh,Judith McKay,James Cassidy,Howard McLeod.Polymorphism in the thymidylate synthase promoter enhancer region incolorectal cancer[J].International Journal of Oncology.2001(2)

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部